Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardiff Oncology (CRDF) Other Operating Expenses (2016 - 2018)

Cardiff Oncology's Other Operating Expenses history spans 10 years, with the latest figure at -$1000.0 for Q4 2024.

  • For Q4 2024, Other Operating Expenses changed N/A year-over-year to -$1000.0; the TTM value through Sep 2025 reached -$1000.0, changed N/A, while the annual FY2020 figure was -$28244.0, 1527.91% down from the prior year.
  • Other Operating Expenses for Q4 2024 was -$1000.0 at Cardiff Oncology, down from $225.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $225.0 in Q4 2020 and bottomed at -$1000.0 in Q2 2020.